 SANTA MARIA, Calif. and MINNEAPOLIS, Sept. 21, 2022 GLOBE NEWSWIRE -- Landec Corporation Nasdaq: LNDC Landec or the Company, a diversified health and wellness company focused on its growing Lifecore Biomedical Lifecore business a fully integrated contract development and manufacturing organization CDMO that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials today announced that it will host a conference call to discuss fiscal 2023 first quarter financial results. The live webcast can be accessed via Landecs website on the Investor Events Presentations page. The webcast will be available for 30 days. 